Nitroxoline Price Trend

Nitroxoline Price Trend, Index and Forecast

Track the latest insights on nitroxoline price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Nitroxoline Prices Outlook Q2 2025

• USA: US$ 327/KG
• Germany: US$ 187/KG
• France: US$ 167/KG
• United Kingdom: US$ 158/KG
• Russia: US$ 207/KG

Nitroxoline Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the nitroxoline prices in the USA reached 327 USD/KG in June. As per the nitroxoline price chart, several critical inputs for the manufacturing of nitroxoline experienced price volatility due to global production challenges, which were exacerbated by ongoing logistical bottlenecks. Delays in raw material shipments, especially from overseas suppliers, disrupted production timelines and created a ripple effect in pricing. On the demand side, healthcare sector trends played a significant role in shaping the price of nitroxoline.

During the second quarter of 2025, the nitroxoline prices in Germany reached 187 USD/KG in June. Throughout the quarter, supply chain disruptions played a major role in shaping the pricing of nitroxoline. Import and production bottlenecks, particularly in key manufacturing hubs, created challenges in ensuring the steady availability of raw materials. This was further compounded by logistical issues at European ports, which caused delays in the delivery of critical intermediates used in the production of nitroxoline. These disruptions in both the supply of raw materials and finished products exerted upward pressure on prices, especially as manufacturers faced longer lead times and higher distribution costs.

During the second quarter of 2025, nitroxoline prices in France reached 167 USD/KG in June. The price of nitroxoline in France was impacted by regulatory and market dynamics. Throughout the quarter, European regulatory bodies continued to monitor the pharmaceutical landscape, which led to some adjustments in pricing policies, particularly for essential medicines like nitroxoline. These policy shifts, while not immediately drastic, set the stage for gradual price corrections and adjustments.

During the second quarter of 2025, the nitroxoline prices in the United Kingdom reached 158 USD/KG in June. While there were some efforts to stabilize production in the UK, many manufacturers faced challenges due to labor shortages and issues within the broader pharmaceutical supply chain. Reduced workforce availability, particularly in key manufacturing plants, resulted in slower production rates for nitroxoline. This slowdown in production coincided with rising demand in the healthcare sector, especially for treatments related to urinary tract infections, which are one of nitroxoline’s primary uses. With production not keeping pace with demand, stockpiles were depleted, further driving up prices.

During the second quarter of 2025, the nitroxoline prices in Russia reached 207 USD/KG in June. Broader economic conditions in Russia played a crucial role. The ongoing impact of inflation, coupled with exchange rate volatility, meant that domestic manufacturers faced higher costs for both imported inputs and operational expenses. In addition, geopolitical factors, particularly tensions between Russia and neighboring countries, introduced uncertainties in international trade and logistics. These issues contributed to the overall economic instability, which indirectly influenced pharmaceutical pricing, including that of nitroxoline.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the nitroxoline prices.

Global Nitroxoline Price Trend

The report offers a holistic view of the global nitroxoline pricing trends in the form of nitroxoline price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of nitroxoline, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed nitroxoline demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Nitroxoline Price Trend

Q2 2025:

Nitroxoline prices in Europe were shaped by a mix of supply, demand, and cost-side developments that shifted market balance over the quarter. At the beginning of the quarter, availability was relatively stable, but procurement interest from the pharmaceutical sector was uneven. Stockpiling from the previous months created some cushion in inventories, which reduced the urgency of fresh buying. As a result, early-quarter transactions were supported more by existing demand pipelines than by new spot orders. On the supply side, production remained consistent, but manufacturers faced cost challenges tied to intermediate inputs and logistics. Feedstock costs eased slightly with better availability in global chemical markets, yet distribution was hindered by transport delays and higher inland freight charges across key European hubs. These issues added friction to deliveries but were not enough to tighten supply significantly.

European nitroxoline prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed nitroxoline price information for a comprehensive list of countries.

North America Nitroxoline Price Trend

Q2 2025:

As per the nitroxoline price index, on the demand side, healthcare and pharmaceutical sectors in North America displayed mixed behavior. The primary use of nitroxoline in treatment for urinary tract infections maintained steady demand, though the growth rate in the overall prescription market slowed. This moderation in growth was largely attributed to the increasing availability of alternative antibiotics and a shifting preference for newer, more targeted treatments. The steady but not expanding demand limited the upward pressure on prices, preventing them from rising sharply despite supply constraints.

The analysis of nitroxoline prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on nitroxoline prices within the United States and Canada can also be provided.

Middle East and Africa Nitroxoline Price Trend

Q2 2025:

The report explores the nitroxoline trends and nitroxoline price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on nitroxoline prices for countries can also be provided.

Asia Pacific Nitroxoline Price Trend

Q2 2025:

As the quarter progressed, market sentiment became more cautious. Suppliers, aware of the ongoing challenges in both production and demand, began to adopt a more conservative approach, limiting production to prevent excess inventory accumulation. While some companies were able to navigate the logistical hurdles and regulatory issues more efficiently, the general sentiment remained one of uncertainty. The combination of supply chain disruptions, regulatory scrutiny, and subdued demand left the market in a holding pattern, with prices adjusting downward slightly by the end of the quarter as conditions normalized.

The nitroxoline pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed nitroxoline prices for a comprehensive list of countries within the region.

Latin America Nitroxoline Price Trend

Q2 2025:

Latin America's nitroxoline market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in nitroxoline prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the nitroxoline price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing nitroxoline pricing trends in this region.

The analysis of nitroxoline prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Nitroxoline Price Trend, Market Analysis, and News

IMARC's latest publication, “Nitroxoline Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the nitroxoline market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of nitroxoline at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed nitroxoline prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting nitroxoline pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Nitroxoline Industry Analysis

The global nitroxoline market is projected to grow at a rate (CAGR) of 3.61%  during 2023-2032.

• The market for nitroxoline is rising as the incidence of urinary tract infections (UTIs) increases globally. UTIs are among the most common bacterial infections that are affecting millions of people, particularly women. Some experts say that there is a 50% chance that women will get one UTI in their lifetime, with many having repeat infections, sometimes for years. Also, about 1 in 10 men will get a UTI in their lifetime. Children can get it as well, though this is rare. The infection rate of children is less than 1 or 2 in 100. There are many factors that contribute to this infection’s prevalence, like poor hygiene practices, a rise in diabetes cases, and the geriatric population. Nitroxoline has been used in treating a wide range of UTI-causing bacteria. The frequent occurrence of UTIs, along with recurrent episodes in many patients, is creating a steady demand for effective treatments.
• The population across the globe is aging, which is creating an increase in the number of geriatric individuals. By 2050, 1 in 6 people on this planet will be over the age of 65. In India, there has been a 41% rise in the population of geriatric people in the last ten years. It is expected that the number of this population group will double by 2025, with 20% of the total population of the country. These adults are more prone to infections due to age-related immunosuppression and the presence of comorbidities such as diabetes and kidney disease. Urinary tract infections (UTIs) are particularly common in this demographic, which creates the need for effective and safe treatment options. Nitroxoline has a favorable safety profile and also gives efficacy in treating UTIs, which makes it an ideal choice for geriatric patients.
• Expenditure on healthcare is rising because of many factors like economic growth, increased health awareness, and governmental initiatives to better healthcare infrastructure. Enhanced access to healthcare services means more people can receive diagnosis and treatment for infections on time. As healthcare systems expand and more people gain access to medical care, the need and demand for effective treatments like nitroxoline surges. For instance, India's public expenditure on healthcare touched 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. The U.S. healthcare spending also saw a hike of 4.1%, reaching $4.5 trillion or $13493/person. This hike in budget allocation for healthcare in these countries and several others is known to improve the accessibility and availability of nitroxoline.
• Chronic diseases like diabetes are impacting the occurrence of infections like UTIs. Diabetic patients are more susceptible to infections because of compromised immune systems and other physiological changes in the body. The increasing incidence of diabetes and related complications is driving the demand for effective antimicrobial treatments like nitroxoline. A total of 38.4 million people have diabetes in the United States. Of these, 29.7 million people, including 29.4 million adults, are already diagnosed, while the other 8.7 million people are undiagnosed. This alarming data has been highlighting the need for effective treatment options in case diabetes excels further to UTI.

Nitroxoline News

The report covers the latest developments, updates, and trends impacting the global nitroxoline industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in nitroxoline production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the nitroxoline price trend.

Latest developments in the nitroxoline industry:

• In February 2023, Asieris Pharmaceuticals revealed that one of its drugs, APL-1202, helped the University of California, San Francisco, save the life of a man who was suffering from a rare brain-eating amoeba, called Balamuthia mandrillaris. APL-1202 is an investigational drug for treating bladder cancer which contains nitroxoline.

Product Description

Nitroxoline is an antimicrobial agent belonging to the 8-hydroxyquinoline family. It operates by inhibiting bacterial deoxyribonucleic acid (DNA) synthesis, thus preventing bacterial proliferation. The compound exists in oral tablet form and in various formulations, including extended-release tablets and solutions. Nitroxoline is used to treat urinary tract infections (UTIs) caused by bacteria such as Escherichia coli, Staphylococcus saprophyticus, and Enterococcus faecalis. It is also used in managing bacterial prostatitis, pyelonephritis, cystitis, and epididymitis.

Nitroxoline offers numerous benefits, such as its broad-spectrum activity, low resistance rates, and minimal side effects. It also provides several advantages, including high bioavailability, ease of oral administration, and a good safety profile. Moreover, nitroxoline demonstrates effectiveness in acute and chronic infections, making it a versatile option in antimicrobial therapy. Its ability to reach high concentrations in urine is particularly advantageous for UTIs, ensuring effective eradication of pathogens.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of nitroxoline pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting nitroxoline price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the nitroxoline industry.